Adult Giant Cell Glioblastoma Completed Phase 1 / 2 Trials for Plerixafor (DB06809)

IndicationStatusPhase
DBCOND0028733 (Adult Giant Cell Glioblastoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01977677Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade GliomaTreatment